Automation Solutions for Clinical Diagnostic Equipment Showcased at AACC 2016
By LabMedica International staff writers Posted on 04 Aug 2016 |

Image: The EXCM – a compact Cartesian handling system for clinical automation (Image courtesy of Festo).
In active demonstrations and static displays, several automated solutions for diagnostics laboratories and manufacturers are being presented by Festo (Hauppauge, NY, USA, and Esslingen am Neckar, Germany) at the 2016 AACC Annual Meeting & Clinical Lab Expo (July 31 - August 4; Philadelphia, PA, USA).
Equipment manufacturers partnering with Festo typically bring products to market faster. As a case in point, Rheonix, Inc. representatives will be in the Festo booth discussing the impact of Festo automation and productivity programs on the development of the company’s EncompassMDx system – a one-stop solution for molecular diagnostic assays. The EncompassMDx automates sample preparation designed to isolate DNA and RNA from a variety of samples. Its detection capabilities combine the capacity of a microarray with the speed and resolution of qPCR in one unit.
In collaboration with New York University College of Dentistry (NYUCD), Rheonix has received funding to develop a rapid diagnostic capability for the Zika virus. The grant will allow the Rheonix/NYUCD team to pursue development of a fully automated screening and self-confirming assay that will simultaneously detect and confirm the presence of Zika virus in a single small sample of saliva or blood. The proposed approach builds upon previous success in which the Rheonix/NYUCD team developed a dual assay for simultaneous detection of HIV antibodies and viral RNA in a single specimen.
One of a number of Festo systems on display is EXCM – a handling system for clinical automation as a compact benchtop Cartesian robot. An active demonstration features the Mini-H gantry with a Z telescope slide axis for microfluidic dosing. Another demonstration simulates the transfer of whole blood from the specimen to an analysis chip within a small footprint device. In this demo, a gripper removes a vial from a tray and transfers it to an integrated rotary gripping unit. The system’s camera reads a barcode and approves eligibility for testing. This demo features the Festo CPX control system, which reduces the complexity of control and motion integration.
Festo also highlights the Single Axis Variable Pitch Module (SVPM) with up to 8 pipettes – it can aspirate or dispense from a 96 well plate, then expand to a different pitch to aspirate or dispense into a large variety of fluid containers such as tubes, chips, or vials.
The AquaJellies from the Festo Bionic Learning Network are artificial, autonomous jellyfish with electric drives and intelligent, adaptive mechanical systems. AACC attendees will see the bionic jellyfish in their new 500 gallon/1,900 liter tank. The movements of the AquaJellies come as close as possible to simulating jellyfish undulating through the world’s oceans. The integrated communication and sensor technology plus the real-time diagnostics enable coordinated, collective behavior among AquaJellies even in a limited space.
Related Links:
Festo
Equipment manufacturers partnering with Festo typically bring products to market faster. As a case in point, Rheonix, Inc. representatives will be in the Festo booth discussing the impact of Festo automation and productivity programs on the development of the company’s EncompassMDx system – a one-stop solution for molecular diagnostic assays. The EncompassMDx automates sample preparation designed to isolate DNA and RNA from a variety of samples. Its detection capabilities combine the capacity of a microarray with the speed and resolution of qPCR in one unit.
In collaboration with New York University College of Dentistry (NYUCD), Rheonix has received funding to develop a rapid diagnostic capability for the Zika virus. The grant will allow the Rheonix/NYUCD team to pursue development of a fully automated screening and self-confirming assay that will simultaneously detect and confirm the presence of Zika virus in a single small sample of saliva or blood. The proposed approach builds upon previous success in which the Rheonix/NYUCD team developed a dual assay for simultaneous detection of HIV antibodies and viral RNA in a single specimen.
One of a number of Festo systems on display is EXCM – a handling system for clinical automation as a compact benchtop Cartesian robot. An active demonstration features the Mini-H gantry with a Z telescope slide axis for microfluidic dosing. Another demonstration simulates the transfer of whole blood from the specimen to an analysis chip within a small footprint device. In this demo, a gripper removes a vial from a tray and transfers it to an integrated rotary gripping unit. The system’s camera reads a barcode and approves eligibility for testing. This demo features the Festo CPX control system, which reduces the complexity of control and motion integration.
Festo also highlights the Single Axis Variable Pitch Module (SVPM) with up to 8 pipettes – it can aspirate or dispense from a 96 well plate, then expand to a different pitch to aspirate or dispense into a large variety of fluid containers such as tubes, chips, or vials.
The AquaJellies from the Festo Bionic Learning Network are artificial, autonomous jellyfish with electric drives and intelligent, adaptive mechanical systems. AACC attendees will see the bionic jellyfish in their new 500 gallon/1,900 liter tank. The movements of the AquaJellies come as close as possible to simulating jellyfish undulating through the world’s oceans. The integrated communication and sensor technology plus the real-time diagnostics enable coordinated, collective behavior among AquaJellies even in a limited space.
Related Links:
Festo
Latest AACC 2016 News
- Molecular Test Detects Three Arboviruses in Plasma Samples
- Derived Exosomal Protein Biomarkers in Alzheimer’s Disease Diagnosis
- New Biochip Array Developed for ApoE4 Classification
- Cell-Free DNA Identifies Liver Transplant Patients with Acute Rejection
- New Method Tested for Early Diagnosis Pediatric Diabetic Nephropathy
- FDA-Cleared Automated Cell Counter for CSF Launched at AACC 2016
- Semen Analysis Portfolio with Two New Products Featured at AACC 2016
- New Tubes Designed for Medium Sample Volumes
- Multi Sample Osmometer Improves Testing Efficiency
- Innovative Information System Optimizes Laboratory Processes
- Innovative eLearning Interface Seamlessly Connects Competency Data
- Cloud-Based Connectivity Platform Advances Decentralized Healthcare
- Adhesives Research to Present Hydrophilic Adhesive Technologies
- Point-of-Care Immunoassay Analyzer on Display at AACC Annual Meeting
- Assay for Determination of 17-OH Progesterone to Be Featured at AACC Annual Meeting
- Fully Automated HbA1c Analyzer Available for Inspection at AACC Annual Meeting
Channels
Clinical Chemistry
view channel
Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
Ovarian cancer is considered one of the deadliest cancers, in part because it rarely shows clear symptoms in its early stages, and diagnosis is often complex. Current approaches make it difficult to accurately... Read more
Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read moreMolecular Diagnostics
view channel
Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk
Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more
Single Cell RNA Sequencing Could Enable Non-Invasive Blood Disorder Diagnosis
Hematologic disorders are often diagnosed using painful, invasive, and expensive bone marrow aspiration or biopsy procedures. These approaches limit patient compliance and broader utility, leaving a need... Read more
Blood Test Identifies HPV-Associated Head and Neck Cancers 10 Years Before Symptoms
Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, and cases are rising each year. Unlike cervical cancers linked to HPV, there is currently no screening test for... Read moreHematology
view channel
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Platelets Could Improve Early and Minimally Invasive Detection of Cancer
Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more
Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read moreImmunology
view channel
Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients
Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more
Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis
Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more
Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more
Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients
Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read moreMicrobiology
view channel
Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
Sepsis arises from infection and immune dysregulation, with neutrophils playing a central role in its progression. However, current clinical tools are unable to both isolate these cells and assess their... Read more
New Diagnostic Method Confirms Sepsis Infections Earlier
Sepsis remains one of the most dangerous medical emergencies, often progressing rapidly and becoming fatal without timely intervention. Each hour of delayed treatment in septic shock reduces patient survival... Read more
New Markers Could Predict Risk of Severe Chlamydia Infection
Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
Vaginal health depends on maintaining a balanced microbiome, particularly certain Lactobacillus species. Disruption of this balance, known as dysbiosis, can increase risks of infection, pregnancy complications,... Read morePathology
view channel
Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma
Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more
Clinicopathologic Study Supports Exclusion of Cervical Serous Carcinoma from WHO Classification
High-grade serous carcinoma is a rare diagnosis in cervical biopsies and can be difficult to distinguish from other tumor types. Cervical serous carcinoma is no longer recognized as a primary cervical... Read moreTechnology
view channel
Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine
The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Rapid Diagnostic Technology Utilizes Breath Samples to Detect Lower Respiratory Tract Infections
Respiratory tract infections (LRTIs) are leading causes of illness and death worldwide, particularly among vulnerable populations such as the elderly, young children, and those with compromised immune systems.... Read moreIndustry
view channel
Werfen and VolitionRx Partner to Advance Diagnostic Testing for Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is a rare autoimmune disorder that causes the immune system to produce abnormal antibodies, making the blood “stickier” than normal. This condition increases the risk of... Read more